Versant Venture Management »

Rayzebio shares owned by Versant Venture Management

Quarter-by-quarter ownership of Rayzebio shares owned by Versant Venture Management from 13F filings

Historical chart of Versant Venture Management investment in Rayzebio

Tip: Access up to 7 years of quarterly data

All positions including Rayzebio held by Versant Venture Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rayzebio by Versant Venture Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $321M 5.2M 62.17
2023-09-30 $115M 5.2M 22.20

More positions owned by Versant Venture Management

RayzeBio Common Stock
CRISPR Therapeutics Common Shares (CRSP)
Repare Therapeutics Common Stock (RPTX)
Gritstone Bio Common Stock (GRTS)
Passage Bio Common Stock (PASG)
Adverum Biotechnologies Common Stock
Aligos Therapeutics Common Stock (ALGS)

View all positions for Versant Venture Management

Top funds holding Rayzebio

Viking Global Investors
venBio Partners
Versant Venture Management
VR Adviser
Wellington Management Company
OrbiMed Advisors
Redmile Group
Samsara BioCapital
Fairmount Funds Management
Cormorant Asset Management
Vanguard Group
Hillhouse Capital Advisors
Deerfield Management Company
Alliancebernstein
Laurion Capital Management

View all funds holding Rayzebio